Skip to main content
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1997 Mar;4(2):226–228. doi: 10.1128/cdli.4.2.226-228.1997

Levels of stem cell factor and interleukin-3 in serum in acute Plasmodium falciparum malaria.

H Burgmann 1, S Looareesuwan 1, E C Wiesinger 1, W Winter 1, W Graninger 1
PMCID: PMC170507  PMID: 9067661

Abstract

The purpose of the present study was to measure serum concentrations of stem cell factor (SCF) and interleukin-3 (IL-3) in patients with acute Plasmodium falciparum malaria. Serum samples from 15 patients were taken on day of admission and days 7, 14, 21, and 28. Anemia developed in 80% of patients. A transient increase in IL-3 could be observed at the beginning of the disease. It remains controversial whether the measured concentrations of IL-3 and SCF correlate with the grade of anemia. The possibly suppressed IL-3 and SCF production may contribute to the prolonged anemia in P. falciparum malaria, as has been shown for erythropoietin.

Full Text

The Full Text of this article is available as a PDF (52.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burgmann H., Hollenstein U., Wenisch C., Thalhammer F., Looareesuwan S., Graninger W. Serum concentrations of MIP-1 alpha and interleukin-8 in patients suffering from acute Plasmodium falciparum malaria. Clin Immunol Immunopathol. 1995 Jul;76(1 Pt 1):32–36. doi: 10.1006/clin.1995.1084. [DOI] [PubMed] [Google Scholar]
  2. Burgmann H., Looareesuwan S., Kapiotis S., Viravan C., Vanijanonta S., Hollenstein U., Wiesinger E., Presterl E., Winkler S., Graninger W. Serum levels of erythropoietin in acute Plasmodium falciparum malaria. Am J Trop Med Hyg. 1996 Mar;54(3):280–283. doi: 10.4269/ajtmh.1996.54.280. [DOI] [PubMed] [Google Scholar]
  3. Hatzigeorgiou D. E., He S., Sobel J., Grabstein K. H., Hafner A., Ho J. L. IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages. J Immunol. 1993 Oct 1;151(7):3682–3692. [PubMed] [Google Scholar]
  4. McNiece I. K., Langley K. E., Zsebo K. M. Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol. 1991 Mar;19(3):226–231. [PubMed] [Google Scholar]
  5. Phillips R. E., Looareesuwan S., Warrell D. A., Lee S. H., Karbwang J., Warrell M. J., White N. J., Swasdichai C., Weatherall D. J. The importance of anaemia in cerebral and uncomplicated falciparum malaria: role of complications, dyserythropoiesis and iron sequestration. Q J Med. 1986 Mar;58(227):305–323. [PubMed] [Google Scholar]
  6. Phillips R. E., Pasvol G. Anaemia of Plasmodium falciparum malaria. Baillieres Clin Haematol. 1992 Apr;5(2):315–330. doi: 10.1016/s0950-3536(11)80022-3. [DOI] [PubMed] [Google Scholar]
  7. Sieff C., Guinan E. In vitro enhancement of erythropoiesis by steel factor in Diamond-Blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor. Stem Cells. 1993 Jul;11 (Suppl 2):113–122. doi: 10.1002/stem.5530110819. [DOI] [PubMed] [Google Scholar]
  8. Woodruff A. W., Ansdell V. E., Pettitt L. E. Cause of anaemia in malaria. Lancet. 1979 May 19;1(8125):1055–1057. doi: 10.1016/s0140-6736(79)92952-0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES